Personal information

Websites & social links

Medical School Hospital
Medical School

Other IDs

ResearcherID: C-4319-2016
Scopus Author ID: 7202505512
Loop profile: 1022004
ResearcherID: C-4319-2016

Keywords

Chronic Urticaria, Basophils, Mast cells, Allergy, Nanoparticles peanut Immunotherapy

Countries

Spain

Activities

Collapse all

Employment (4)

University of Navarra: Pamplona, ES

2022-01-24 to present | Dean (School of Medicine)
Employment
Source: Self-asserted source
Marta Ferrer

Universidad de Navarra: Pamplona, ES

2021-01-01 to present | Full Professor of Medicine (Allergy)
Employment
Source: Self-asserted source
Marta Ferrer

Clinica Universitaria de Navarra: Pamplona, Navarra, ES

2007-08-16 to present | Department Head (Allergy)
Employment
Source: Self-asserted source
Marta Ferrer

Universidad de Navarra: Pamplona, Navarra, ES

2019-09-01 to 2022-01-23 | Medical Director (Medical School Hospital)
Employment
Source: Self-asserted source
Marta Ferrer

Education and qualifications (1)

Universidad de Navarra Facultad de Medicina: Pamplona, Navarra, ES

1979-10-01 to 1995-05-17 | Full Professor (Allergy)
Education
Source: Self-asserted source
Marta Ferrer

Professional activities (4)

Sociedad Española de Alergologia: Madrid , ES

2020-09-01 to present | Board Member
Service
Source: Self-asserted source
Marta Ferrer

American Academy of Allergy Asthma and Immunology: Milwaukee, WI, US

1999 to present | Fellow
Membership
Source: Self-asserted source
Marta Ferrer

European Academy of Allergy and Clinical Immunology: Zurich, CH

1996-05 to present
Membership
Source: Self-asserted source
Marta Ferrer

Imperial College: London, GB

2021-09-01 to 2024-06-30 | External Examiner (National Heart and Lung Institute)
Invited position
Source: Self-asserted source
Marta Ferrer

Funding (6)

Análisis de la expresión génica de los basófilos y del proteoma serio en pacientes con urticaria cónica y angioedema histaminérgico

2021-01 to 2024-01 | Award
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Marta Ferrer

Ensayo Clínico Fase I para determinar la eficacia de una inmunoterapia oral basada en nanopartículas para el tratamiento de alergias alimentarias (NANOVAC

2020-01 to 2023-12 | Award
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

RTC2019-006977-1
Source: Self-asserted source
Marta Ferrer

Caracterización tanto fenótipica como genotípica del angioedema histaminérgico

2017-01-01 to 2019-12-31 | Grant
Institute of Health Carlos III (Madrid, ES)
URL: https://app.dimensions.ai/details/grant/grant.8100411
GRANT_NUMBER: PI16%2f01304
Source: Self-asserted source
Marta Ferrer via DimensionsWizard

Desarrollo de una inmunoterapia oral basada en nanopartículas para el tratamiento de alergias alimentarias

2015-09 to 2018-12 | Award
Ministerio de Economía y Competitividad (Madrid, ES)
GRANT_NUMBER:

RTC-2015-3826-1
Source: Self-asserted source
Marta Ferrer

Diseño de nuevas formas farmacéuticas para administración de inmunoterapia oral para el tratamiento de alergia alimentaria a cacahuete

2010-03 to 2013-03 | Award
Fundación Ramón Areces (Madrid , ES)
GRANT_NUMBER:

RA/2010
Source: Self-asserted source
Marta Ferrer

DISEÑO DE NUEVAS FORMAS FARMACÉUTICAS PARA ADMINISTRACIÓN DE INMUNOTERAPIA ORAL PARA EL TRATAMIENTO DE ALERGIA ALIMENTARIA AL CACAHUETE

2010-01 to 2012-12 | Award
Instituto de Salud Carlos III (Madrid , ES)
GRANT_NUMBER:

PS09/01083
Source: Self-asserted source
Marta Ferrer

Peer review (86 reviews for 8 publications/grants)

Review activity for Allergy. (63)
Review activity for BMJ case reports. (1)
Review activity for BMJ open. (2)
Review activity for British journal of dermatology (6)
Review activity for Clinical and experimental allergy. (8)
Review activity for Clinical and experimental dermatology (2)
Review activity for Clinical and translational allergy. (3)
Review activity for The lancet. (1)
How many people are using ORCID?